Carolyn Haunschild , MD and Sameer Sharma, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding and discuss how risk of complications, morbidity and mortality of patient management factor into billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Subcommittee.

Kimberly Levinson, MD, MPH, and Kaitlin Nicholson, MD, from the SGO Coding and Reimbursement Committee share their expertise in E/M coding to demystify the use of medical complexity data to support your billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee. 

This is the first of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. After going over some general information on CDK 4/6 inhibitors including when to use the drug, toxicity, response rates, repeat biopsy, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving CDK 4/6 inhibitors. The session wraps up with some key take home points on CDK 4/6 inhibitors.

2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator:
Jennifer MacDonald, PharmD, BCOP
 
Speakers: 
Julia Fehniger, MD
Jodi L. Taraba, PharmD, MS, RPh, BCOP
Siddhartha Yadav, M.B.B.S, MD

Let’s do this -- This podcast features patient advocates who share their experiences and offer valuable insights from their journeys as cervical cancer patients and survivors. It is hosted by the Health Equity Subcommittee, a division of the SGO Diversity, Inclusion, and Health Equity (DIHE) Committee.

Moderators:

• Lindsay Kuroki, MD, MSCI, Washington University Physicians, DIHE Health Equity subcommittee Chair
• Nancy Zhou, MD, Rutgers Health - NJMS, DIHE Health Equity subcommittee Member

 Speakers:

• Mindy Dunn, Cancer Survivor
• Linda Ryan, Cancer Survivor and Patient Advocate 

Resource Links:
Foundation for Women's Cancer (FWC) Cervical Cancer: Your Guide 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®.  

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:
Tracilyn Hall, MD

Speakers:
Jennifer MacDonald, PharmD, BCOP
Kathleen Moore, MD
Bernard Tawfik, MD 

In honor of Endometrial Cancer Awareness Month, we encourage you to read the latest HER2 Molecular Card and Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card available now on SGO ConnectEd.

HER2 Molecular Card: https://connected.sgo.org/content/molecular-target-human-epidermal-growth-factor-receptor-2-her2

Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card: https://connected.sgo.org/content/chemotherapy-targeted-therapies-flash-cards

This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®.  Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®.  Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:
Tracilyn Hall, MD

Speakers:
Jennifer MacDonald, PharmD, BCOP
Kathleen Moore, MD
Bernard Tawfik, MD 

In honor of Endometrial Cancer Awareness Month, we encourage you to read the latest HER2 Molecular Card and Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card available now on SGO ConnectEd.

HER2 Molecular Card: https://connected.sgo.org/content/molecular-target-human-epidermal-growth-factor-receptor-2-her2

Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card: https://connected.sgo.org/content/chemotherapy-targeted-therapies-flash-cards

This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving Trastuzumab Deruxtecan ENHERTU®. The session wraps up with some key take home points on Trastuzumab Deruxtecan ENHERTU®. 

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:
Tracilyn Hall, MD

Speakers:
Jennifer MacDonald, PharmD, BCOP
Kathleen Moore, MD
Bernard Tawfik, MD 

In honor of Endometrial Cancer Awareness Month, we encourage you to read the latest HER2 Molecular Card and Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card available now on SGO ConnectEd.

HER2 Molecular Card: https://connected.sgo.org/content/molecular-target-human-epidermal-growth-factor-receptor-2-her2

Trastuzumab Deruxtecan ENHERTU® Chemotherapy Card: https://connected.sgo.org/content/chemotherapy-targeted-therapies-flash-cards

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).

Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity. 

Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (SDD).

2023-2024 SGO ERAS Subcommittee Members and Speakers:
Lee-may Chen, MD; Subcommittee Lead and Moderator
Nawar Latif, MD, MPH, MSCE
Clarissa Polen-De, MD
Michael Shu, MD
Collin Sitler, DO
Brenna Swift, MD, MASc, MSc, FRCSC
Diogo Torres, MD

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing.

Moderator:
Karin K. Shih, MD
Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell

Speakers:
Erin Zacholski, PharmD, BCOP
Assistant Professor - VCU School of Pharmacy
Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center

Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticosteroids, re-challenging after toxicity, use of ICIs in patients with auto-immune conditions, and drug interactions.

Moderator:
Karin K. Shih, MD
Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell

Speakers:
Erin Zacholski, PharmD, BCOP
Assistant Professor - VCU School of Pharmacy
Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center

Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

Join Dr. Robert Neff as he interviews Drs. Kathleen Moore and Charles Leath, III to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.  

 Some questions covered during the interview:

1.  Since NRG just celebrated its 10-year anniversary during the Summer Meeting, what is the vision for NRG in the next 10 years?
2. What are some of the successes within the past year for the Ovary Subcommittee?
3. What were the most important highlights from the Cervix and Vulvar Subcommittee?
4. Are there opportunities for new members to be involved? 

This episode was created by Dr. Robert Neff, 2023-2024 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Moore and Leath, III for your contribution to this episode.

Moderator:
Robert Neff, MD

Speakers:
Kathleen Moore, MD
Charles Leath, III, MD 

Episode three of the Radiation Therapy podcast series discusses radiation techniques and management with regard to locally advanced cervical cancer. 

Host/Moderator:
Leigh A. Cantrell, MD, MSPH
Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - University of Virginia

Guest Speaker:
Kara Romano, M.D.
Assistant Professor, Department of Radiation Oncology - University of Virginia

As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. 

Tune in to part two, as the discussion continues between Dr. Emily Wu and the panel of nurse navigators on the multi-faceted function of navigators and how to incorporate nurse navigation into a clinical practice. 

Moderator:
Emily Wu, MD
Overlake Medical Center 

Speakers:
Julie Rodriguez, BSN, RN, OCN 
University of New Mexico 

Jordan Henderson, BSN, RN, OCN, ONN-CG 
Director of Program Development, AONN+

Sally (Cannon) Tormey, RN, BSEd, OCN 
HCA TriStar

Join Dr. Janelle Darby, member of the SGO Clinical Trials Management/Concepts Subcommittee, as she interviews Drs. Evan Graboyes, Jeffrey Hines, and Bhavana Pothuri, addressing continued efforts to improve inclusion of racially and ethnically diverse patients in clinical trials.   

Some topics covered during the interview:

1. Barriers to clinical trial enrollment and retention among racially and ethnically diverse patient populations.
2. Role of cooperative research groups in improving access to clinical trials for racially and ethnically diverse patient populations. 
3. Discussion of resources and strategies to improve recruitment and retention of racially and ethnically diverse patient populations in clinical trials.

2023-2024 SGO  Clinical Trials Management/Concepts Subcommittee Member and Moderator:
Janelle Pakish Darby, MD

Speakers:
Evan Graboyes, MD, MPH, FACS
Jeffrey Hines, MD
Bhavana Pothuri, MD, MS

This podcast focuses on the surgical site infection reduction bundle as part of the ERAS guidelines that was first published in 2016 and updated in 2019, and the 2020 vulvar and vaginal surgeries ERAS guidelines.

Before we dive into the SSI reduction bundle, we want to highlight the importance of patient education and participation in any ERAS protocol. Pre-operative education and psychological preparation is critical. Written information was determined to be superior to verbal in a randomized clinical trial in gynecologic oncology surgery.

2023-2024 SGO ERAS Subcommittee Members and Speakers:
Lee-may Chen, MD; Subcommittee Lead and Moderator
Nawar Latif, MD, MPH, MSCE
Collin Sitler, DO
Brenna Swift, MD, MASc, MSc, FRCSC

This is the last of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trabectedin and Doxorubicin. When to dose adjust and hold or even discontinue Trabectedin and Doxorubicin. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trabectedin and Doxorubicin.  

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Sminu Bose, MD
Joshua Cohen, MD 
Claire Marie Mach, PharmD, BCOP    

This is the second of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trabectedin and Doxorubicin. Focusing on oral dosing, infusion pump setup, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
 Jennifer MacDonald, PharmD, BCOP

Speakers:
Sminu Bose, MD
Joshua Cohen, MD 
Claire Marie Mach, PharmD, BCOP    

This is the first of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. After going over some general information on Trabectedin and Doxorubicin including when to use the drug, checking patient performance status, toxicity, and line of therapy and treatment option for recurring metastasis disease. The multidisciplinary panel will discuss dosing and drug preparation for giving Trabectedin and Doxorubicin. The session wraps up with some key take home points on Trabectedin and Doxorubicin.  

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Sminu Bose, MD
Joshua Cohen, MD 
Claire Marie Mach, PharmD, BCOP    

Episode two of the Radiation Therapy podcast series discusses treatment of Oligometastatic disease, re-irradiation and role of palliative radiation, utilization of SBRT, introduction to proton therapy and mitigation of radiation-associated toxicities.

Host:
Mian M. Shahzad, MD, PhD
Gynecologic Oncologist, H. Lee Moffitt Cancer Center

Guest Speaker: 
Michael Montejo, MD
Radiation oncologist, H. Lee Moffitt Cancer Center 

This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities.

Moderator:
Karin K. Shih, MD
Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell

Speakers: 
Erin Zacholski, PharmD, BCOP 
Assistant Professor - VCU School of Pharmacy
Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center
 
Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 1 of the Radiation Therapy podcast series, which looks to review and address the basic fundamentals of radiation therapy in the gynecologic oncology setting.

Host: Mian M. Shahzad, MD PhD (Gynecologic Oncologist; H. Lee Moffitt Cancer Center)

Guest Speaker: Michael Montejo, MD (Radiation oncologist; H. Lee Moffitt Cancer Center) 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trametinib. When to dose adjust and hold or even discontinue Trametinib. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trametinib. 

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

This is the second of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trametinib. Focusing on oral dosing, lab examinations, prophylactic management of skincare reactions, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. Given the complexities of our healthcare systems, this episode provides insight on ways a clinical practice can better support their patients.

Tune in to this two-part episode as the Dr. Emily Wu interviews a panel of nurse navigators on their unique experiences within the role, the multi-faceted function of navigators, and how to incorporate nurse navigation into a clinical practice. 

Moderator:
Emily Wu, MD
Overlake Medical Center 

Speakers:
Julie Rodriguez, BSN, RN, OCN 
University of New Mexico 

Jordan Henderson, BSN, RN, OCN, ONN-CG 
Director of Program Development, AONN+

Sally (Cannon) Tormey, RN, BSEd, OCN 
HCA TriStar

This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicity, and line of therapy. The multidisciplinary panel will discuss dosing and drug preparation for giving Trametinib. The session wraps up with some key take home points on Trametinib.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

The goal of this podcast is to continue our series on key concepts of enhanced recovery after surgery (ERAS). In September 2022, the SGO Education Committee's ERAS Subcommittee discussed why we do it, and in February 2023, we talked about how we do it. This podcast will complete our trilogy and discuss implementation or looking at how well we do it.

Listen to Gregg Nelson, MD, PhD from the University of Calgary discuss ERAS implementation including some of the starting points, his experience in his own institution, and key ERAS lessons learned.  Dr. Nelson is the Deputy Head of the Department of Obstetrics & Gynecology at the Cumming School of Medicine in Calgary, Alberta, Canada and is Chief of Gynecologic Oncology at the Tom Baker Cancer Centre. He is also on the Executive Committee for the international ERAS® Society, and a lead author for the ERAS® Society gynecologic guidelines.

2023-2024 ERAS Subcommittee Moderator and Podcast Script Editor:
Lee-may Chen, MD

2022-2023 Opioid/ERAS Subcommittee Members:
Jing-Yi Chern, MD (Moderator)
Amanika Kumar, MD (Podcast Script Editor)

Podcast Invited Speaker:
Gregg Nelson, MD, PhD 

Let’s face it, wellness is an ever-evolving concept. Listen in as we celebrate aspects of wellness throughout the SGO community. These are 10–20-minute quarterly snippets to highlight the authentic voices from SGO and beyond. Stay connected and foster community in between SGO meetings. You can find these episodes anywhere you get your SGO on the Go podcasts.

To view the SGO Wellness Curriculum, click here. 

Join Dr. Kathryn Mills as she interviews Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.  

Some questions covered during the interview:

1. What are some of the upcoming trials in your disease site that you are most excited about?
2. What advice would you give sites considering opening some of the trials that are available?
3. How can sites get more efficient at screening and enrollment?
4. How can sites increase enrollment of minorities?

This episode was created by Dr. Kathryn Mills, a former 2022-2023 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev for your contribution to this episode.
 
Moderator:
Kathryn Mills, MD

Speakers:
Jubilee Brown, MD
Ann Klopp, MD, PhD
Joyce Liu, MD, MPH
Jyoti Mayadev, MD 

This is the last of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Mirvetuximab soravtansine. The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Mirvetuximab soravtansine. Once again, the session ends with take home points for patient monitoring while on Mirvetuximab soravtansine.  

2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO 
Karen Lyle, PA-C
Kathleen Moore, MD 

This is the second of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Mirvetuximab soravtansine. Focusing on eye drop prescriptions, home medications, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 

2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO 
Karen Lyle, PA-C
Kathleen Moore, MD

This is the first of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. After going over some general information on Mirvetuximab soravtansine including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of APP, Optometrist, and Gynecologic Oncologist educated and prepared for giving Mirvetuximab soravtansine. The session wraps up with some key take home points on Mirvetuximab soravtansine.  

2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO 
Karen Lyle, PA-C
Kathleen Moore, MD

The goal of this podcast is to follow-up Key Concepts of enhanced recovery after surgery (ERAS), and this podcast is divided into sections referring to pre-operative, intraoperative, and postoperative considerations. We hope to provide some practical tips on how to develop a successful ERAS program at your institution. We acknowledge that all health systems are a little different. Yet there are some common strategies that can be used in developing collaborations.  In conclusion, how to implement ERAS is to foster communication between various team members, including the patient. We hope this podcast helps to set expectations and promote working in concert to bear the fruit of improved patient outcomes. 

2022-2023 SGO Opioid/ERAS Subcommittee Members and Speakers:
Lee-may Chen, MD; Subcommittee Lead
Jing-Yi Chern, MD
Sharmilee Korets, MD
Amanika Kumar, MD
Andras Ladanyi, MD, PhD
Matthew Wagar, MD
Erin Hickey Zacholski, PharmD

Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Yasmin Lyons, DO and Lisa Rauh, MD discuss the best cervical, vulvar and vaginal cancer resources when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and joining a study group, visiting the SGO ConnectEd, meeting with your local radiation oncologist to discuss radiation in general and your individual patients managed, knowing landmark trials for prognostic factors (GOG 36), surgery for early-stage vulvar cancer, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices.

ABOG and SGO Collaboration
During the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases.        

Resources

• Click here to access SGO ConnectEd to review additional resources on Cervical, Vulvar and Vaginal Cancer.
• NCCN guidelines, UpToDate, and GYOEDU.ORG.

Listen to Tracilyn Hall, MD, co-chair of the SGO Taskforce for Board Certification Support, interview Claire Hoppenot, MD and Alexander Melamed, MD discussing the best resources for Uterine Malignancies (endometrial cancer) and GTD Considerations when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding reviewing for the ABOG Gynecology Oncology Certifying Exam.  They will help you reference the ABOG bulletin, resources on the SGO ConnectEd website, as well as relevant studies. In addition to this podcast, the taskforce will offer other informative podcasts focused on high yield topics and best preparation practices.

ABOG and SGO Collaboration
During the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA,  representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases. 

Resources

• Click here to access SGO ConnectEd to review additional resources on Uterine Malignancies and GTD Considerations.
• The ABOG Gynecology Oncology Exam bulletin, which has a comprehensive list of possible topics. As for some just general good places to focus as it gets closer to the time of the exam think about NCCN guidelines, UpToDate, and GYOEDU.ORG.

Allison Barrie, MD, and Stephen Bush, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding to unlock the secrets of using the number and complexity of diagnoses to support your billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Chair of the SGO Coding and Reimbursement Subcommittee. 

Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Anna Beavis, MD and Robert Neff, MD discuss the best ovarian cancer resources on surgical considerations, chemotherapy, and genetic testing when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and grouping your cases to see their similarities/differences, management of toxicities of common targeted therapies for gynecologic cancers, the benefits of joining a study group, attending the SGO Annual Meeting sessions to gain insight, knowing the FDA indications, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices.
 
ABOG and SGO Collaboration
During the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA,  representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases.

Resources

• Click here to access SGO ConnectEd to review additional resources on Ovarian Cancer.
• Review NCCN guidelines, UpToDate, and GYOEDU.ORG.
• Listen to Key Concepts of Enhanced Recovery After Surgery. ERAS–Why Do We Do It? 
• There are SGO ConnectEd chemo flash cards that are high yield when it comes to toxicities.

 Special thanks to Drs. Beavis and Neff for your contribution to this episode.

This is the last of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Lenvatinib/pembrolizumab.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Lenvatinib/pembrolizumab. Once again, the session ends with take home points for patient monitoring while on Lenvatinib/pembrolizumab.  

2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Jennifer MacDonald, Pharm.D, BCOP
Pamela Soliman, MD

This is the second of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Lenvatinib/pembrolizumab. Focusing on specialty pharmacy and patient education when taking Lenvatinib at home. The session ends with general take home points on administration and toxicity prevention interventions. 

2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Dew Hilton, Specialty Pharmacy Technician 
Jennifer MacDonald, Pharm.D, BCOP
Pamela Soliman, MD

This is the first of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. After going over some general information on Lenvatinib/pembrolizumab including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of nursing, pharmacy, Gynecologic Oncologist educated and prepared for giving Lenvatinib/pembrolizumab. The session wraps up with some key take home points on Lenvatinib/pembrolizumab.  

2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Jennifer MacDonald, Pharm.D, BCOP
Pamela Soliman, MD

Listen to Tracilyn Hall, MD, co-chair of the SGO Taskforce for Board Certification Support, interview Gillian Hsieh, MD and Lavanya H. Palavalli Parsons, MD discussing the best resources for ICU and Perioperative Considerations when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding reviewing your anatomy textbooks and case list to see what co-morbidities your patients have, visiting the SGO ConnectEd for perioperative care topics, knowing what technology and protocol you have at your institution as well as published data, studying bowel injuries, and having tumor board discussions to guide interventions, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices.

During the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA,  representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases. 

Resources

• Click here to access SGO ConnectEd to review additional resources on ICU and Perioperative Considerations.
  1. Listen to Key Concepts of Enhanced Recovery After Surgery. ERAS–Why Do We Do It?
  2. There are SGO ConnectEd chemo flash cards that are high yield when it comes to toxicities.
•  Read “Principles and Practice of Gynecologic Oncology” and “Gynecologic Oncology Handbook,” which provides some good quick sections on ICU topics.
• American Society of Clinical Oncology (ASCO) is another organization that has great guidelines that can easily be accessed here. 

 Special thanks to Drs. Hsieh and Parsons for your contribution to this episode.

The success of an effective clinical research program is essential for developing and maintaining a top-tier clinical research trial team. Join our next podcast on clinical trial management as Dr. Robert Neff interviews Dr. Bradley Monk, Dr. Mark Shahin, and Ashley Douglas, RN, BSN, OCN addressing clinical trials from a community oncology perspective. The discussion includes building a quality clinical trial team, relationship development with industry partners, cooperative group involvement (NRG), the process for initiating clinical research at home institution, and important pitfalls to avoid as a new researcher among other topics.
 
 This episode was moderated by Robert Neff, MD, a member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. 

Special thanks to Bradley Monk, MD, Mark Shahin, MD, and Ashley Douglas, RN, BSN, OCN for your contribution to this episode.

This episode features recent updates presented at the 2022 European Society for Medical Oncology (ESMO) Congress in Paris, France. SOLO1 study survival data, PAOLA data, and information about novel, early-phase drugs and their practice implications are reviewed by three speaker experts. 

This is an educational resource produced through collaboration between the Society of Gynecologic Oncology (SGO) and the Cancer Association of Community Cancer Centers (ACCC). 

Join us as Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, interviews Janelle Darby, MD and Kathryn Mills, MD to discuss best resources for radiation oncology when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, radiation prevention strategies, the benefits of joining a study group, reviewing treatment and management of the patients on your case list, knowing the principles of radiation and how it is administered, discussing treatment decisions with your local radiation oncologist, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices. 

ABOG and SGO Collaboration
During the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA,  representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases. 

Resources
Click here to access SGO ConnectEd to review additional resources on radiation oncology. 

1. Radiation Planning Principles for Gynecologic Oncology (part of the Fellow Core Lecture Series) – Hour long lecture from Anuja Jhingran, MD at MD Anderson that reviews radiation fields, IMRT, specific organ dose limits, vaginal brachytherapy delivery to name a few. This is a good overview of radiation basics and treatment for the different disease sites.  
2. SGO Fellows Bootcamp – Another introductory lecture on radiation oncology that was created for new fellows and provides a nice overview.

Click here to access the full-text guideline titled, “Radiation Therapy for Cervical Cancer: An ASTRO Clinical Practice Guideline,” which provides recommendations on the use of radiation therapy to treat adult women with cervical cancer. 

Special thanks to Drs. Darby and Mills for your contribution to this episode.

Join Dr. Hall, Co-Chair of the SGO Taskforce for Board Certification Support, as she interviews Drs. Mallen and Zeligs, who recently took the ABOG board exam, addressing several different approaches to case list preparation. As part of the taskforce, we have recognized several SGO members who had taken the ABOG board exam have different approaches to their case list preparation, and we wanted to make sure we provide effective resources for all of those candidates coming up this year on what we were able to be successful with our case list. Some questions covered during the interview:

1. What is the timeline for case list creation and submission?
2. How many cases do I need?
3. What cases do I need to include on my list?
4. What about the ABOG approved abbreviations?
5. When should I have the required affidavits signed?

The taskforce will also offer other informative podcasts focused on high yield topics and best preparation practices.

ABOG and SGO Collaboration
During the SGO 2024 Annual Meeting on Women’s Cancer in San Diego, CA,  representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process and there will be a presentation covering radiation oncology. Keep an eye for this session opportunity when registering for the upcoming SGO 2024 Annual Meeting and be sure to sign up if interested in participating. We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases.

Special thanks to Drs. Mallen and Zeligs for your contribution to this episode.

Moderator:
Tracilyn Hall, MD

Speakers:
Adrianne Mallen, MD
Kristen Zeligs, MD

Join Dr. AlHilli as she interviews Dr. Amanda Nickles Fader addressing specific questions of mentorship, conducting clinical trials and rare disease in gynecologic oncology, and having success in clinical trials. Dr. Fader also discussed the SGO BRIDGES Research Initiative, a new, longitudinal clinical trials workshop for early career investigators with the aim of developing the next generation of trialists who will lead investigator-initiated and cooperative group gynecologic cancer clinical studies. It is designed to bridge the gap between translational scientists and clinical trialists in gynecologic oncology by providing formal training for young investigators in clinical trial design, connecting participants with expert mentors, and supporting the development of novel clinical trials.
 
 This episode was created by Mariam AlHilli, MD, a member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Amanda Nickles Fader, MD for your contribution to this episode.

During the SGO 2024 Winter Meeting, Wellness Committee volunteers asked SGO members what advice they would give to their younger selves. Members at various stages of their medical career offered words of wisdom for trainees and new attendings in gynecologic oncology. Tune in to hear about challenges that members experienced, their journey to growth and self-care, and how they learned to find support through community and mentorship. 

Moderator: Hui (Amy) Chen, MD
Speakers: Katherine Fuh, MD, PhD; Jessica Gillen, MD; Allison Puechl, MD; Jeb Brown, MD; Katie Essel, MD; Katya Papatla, MD; Lisa Landrum, MD, PhD; Ramez Eskander, MD; Ritu Salani, MD, MBA; Wendel Naumann, MD; Sarah Johnson, PharmD; Sarah Ackroyd, MD, MPH; Kathryn McGonigle, MD 

This is the last of the three-part podcast series, Keeping up with the Chemos on tisotumab vedotin.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on tisotumab vedotin.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue tisotumab vedotin. Once again, the session ends with take home points for patient monitoring while on tisotumab vedotin.  

2022-2023 Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO
Shannon Westin, MD 
Erin Hickey Zacholski, Pharm.D

This is the second of the three-part podcast series, Keeping up with the Chemos on tisotumab vedotin. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of tisotumab vedotin. Focusing in ophthalmology exam prior to each cycle, use of ice packs and eye drop regimen to give prior to infusion and post infusion at home to prevent toxicity. The session ends with general take home points on administration and toxicity prevention interventions. 

2022-2023 Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO
Shannon Westin, MD 
Erin Hickey Zacholski, Pharm.D

Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the first of the three-part podcast series, Keeping up with the Chemos on tisotumab vedotin. After going over some general information on tisotumab vedotin including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of nursing, pharmacy, Gynecologist and Ophthalmologist/Optometrist educated and prepared for giving tisotumab vedotin. The session wraps up with some key take home points on tisotumab vedotin. 

2022-2023 Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO
Shannon Westin, MD 
Erin Hickey Zacholski, Pharm.D

For this latest installment, we have decided to go back to the beginning, and return to key concepts of Enhanced Recovery After Surgery. ERAS–why do we do it? What are the guiding principles? In the next 20 minutes, our working group discussants will address key elements of ERAS and why we do it.

2022-2023 Opioid/ERAS Subcommittee Speakers:
Lee-may Chen, MD
Jing-Yi Chern, MD
Sharmilee Korets, MD
Andras Ladanyi, MD, PhD
Matthew Wagar, MD
Erin Hickey Zacholski, PharmD

2022-2023 Opioid/ERAS Subcommittee Member and Podcast Script Editor:
Amanika Kumar, MD